Learn how the coinsurance formula affects your home insurance claim reimbursement, why maintaining 80% coverage is crucial, and see examples to avoid penalties.

Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs. Impacted doses ...

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...

Novo Nordisk on Tuesday said it's lowering the list price for its blockbuster weight-loss and diabetes drugs by as much as ...

Florida’s growing senior population drives demand for cost-conscious coverage as 2026 healthcare costs, Medicare rules ...